Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-01

Clinical Trial Update: Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating safety and effectiveness of Trappa Ethanolamine tablets combined with Ciclosporin for non-severe aplastic anemia is reported as ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclosporin (cyclosporine)
  • Trappa Ethanolamine tablets (trappa ethanolamine)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Non-severe Aplastic Anemia | Phase 2 | Status: UNKNOWN